MicroRNA News and Research

RSS
In genetics, microRNAs (miRNA) are single-stranded RNA molecules of 21-23 nucleotides in length, which regulate gene expression. miRNAs are encoded by genes from whose DNA they are transcribed but miRNAs are not translated into protein (i.e. they are non-coding RNAs); instead each primary transcript (a pri-miRNA) is processed into a short stem-loop structure called a pre-miRNA and finally into a functional miRNA. Mature miRNA molecules are partially complementary to one or more messenger RNA (mRNA) molecules, and their main function is to down-regulate gene expression.
Mirina closes Versant led Series A-1 financing

Mirina closes Versant led Series A-1 financing

Mechanisms pathogenic viruses exploit to evade immune systems of hosts

Mechanisms pathogenic viruses exploit to evade immune systems of hosts

Johns Hopkins scientist receives AACR Award for Outstanding Achievement in Cancer Research

Johns Hopkins scientist receives AACR Award for Outstanding Achievement in Cancer Research

Alnylam Pharmaceuticals presents new data on ALN-TTR01 RNAi therapeutic at amyloidosis symposium

Alnylam Pharmaceuticals presents new data on ALN-TTR01 RNAi therapeutic at amyloidosis symposium

WaferGen Biosystems introduces SmartChip Multi-Sample Dispenser for faster biomarker validation

WaferGen Biosystems introduces SmartChip Multi-Sample Dispenser for faster biomarker validation

MicroRNAs control levels of Myc protein in Drosophila: Researchers

MicroRNAs control levels of Myc protein in Drosophila: Researchers

miRNAs may generate new insights on cancer and possible future treatments

miRNAs may generate new insights on cancer and possible future treatments

NanoString Technologies launches new miRNA assay kits

NanoString Technologies launches new miRNA assay kits

UAB researchers discover four miRNAs to assess survival rate of colorectal cancer patients

UAB researchers discover four miRNAs to assess survival rate of colorectal cancer patients

Biomarkers to help predict development of aggressive colorectal cancer discovered

Biomarkers to help predict development of aggressive colorectal cancer discovered

TGen, Asuragen sign microRNA technology agreement for pancreatic cancer research

TGen, Asuragen sign microRNA technology agreement for pancreatic cancer research

MiRNA-21 interferes with Herceptin therapy, says study

MiRNA-21 interferes with Herceptin therapy, says study

Regulus Therapeutics' metabolic disease program data presented at Diabetes Keystone Symposium

Regulus Therapeutics' metabolic disease program data presented at Diabetes Keystone Symposium

Researchers identify new strategy for treating acute myeloid leukemia

Researchers identify new strategy for treating acute myeloid leukemia

High level of microRNAs found in patients with high-risk multiple myeloma

High level of microRNAs found in patients with high-risk multiple myeloma

RXi Pharmaceuticals, miRagen Therapeutics enter into research collaboration

RXi Pharmaceuticals, miRagen Therapeutics enter into research collaboration

RXi Pharmaceuticals, Mirna Therapeutics form microRNA research collaboration

RXi Pharmaceuticals, Mirna Therapeutics form microRNA research collaboration

Rosetta Genomics to present posters on microRNA-based technologies at AACR 2010

Rosetta Genomics to present posters on microRNA-based technologies at AACR 2010

USPTO allows Alnylam Pharmaceuticals' new claims from Woppmann et al. patent series

USPTO allows Alnylam Pharmaceuticals' new claims from Woppmann et al. patent series

Rosetta Genomics' Philadelphia lab commences FNA cell block sample analysis with miRview squamous test

Rosetta Genomics' Philadelphia lab commences FNA cell block sample analysis with miRview squamous test

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.